Dr Lal Pathlabs Ltd (LALPATHLAB) is currently trading at 1,443.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Dr. Lal PathLabs is a leading diagnostic healthcare service provider in India, offering over 5000 tests through an extensive national network of labs and service centers. Despite industry challenges, the company achieved a 10.6% YoY increase in revenue for Q3 FY26, underscoring its ability to sustain growth through strategic moves like network expansion and introduction of new tests. The launch of Sovaaka, a personalized preventive healthcare platform, has been pivotal, marking a shift towards preventive and predictive healthcare services, leveraging advanced diagnostics and AI technology. Significant strides in increasing high-end diagnostic portfolios signal the company's focus on capturing a larger share of the preventive and specialty diagnostics markets, particularly through specialized centers and new test introductions. Dr. Lal PathLabs' financial resilience is evident from its robust EBITDA margins and strategic reinvestment in growth areas like high-end radiology, demonstrating both operational efficiency and strategic foresight.

Over the past 52 weeks, Dr Lal Pathlabs Ltd has traded between a low of ₹1,147.55 and a high of ₹1,771.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Dr Lal Pathlabs Ltd has a market capitalization of approximately 24,184.89. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Dr Lal Pathlabs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 44.06 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Dr Lal Pathlabs Ltd (LALPATHLAB) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 24,184.89 Cr, Dr Lal Pathlabs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Dr Lal Pathlabs Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Dr Lal Pathlabs Ltd is 44.06. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Dr Lal Pathlabs Ltd pays dividends with a current dividend yield of 0.83%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Dr Lal Pathlabs Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.